Vincent A Vultaggio's Insider Trades & SAST Disclosures

Vincent A Vultaggio's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 29,951 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on Feb. 6, 2026.

Share

Note

This is a custom search result for pattern Vincent A Vultaggio.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Zentalis Pharma Inc	Vincent A Vultaggio	PAO and PFO	Sale of securities on an exchange or to another person at price $ 2.43 per share.	06 Feb 2026	29,951	156,779	-	2.4	72,772	Common Stock
Zentalis Pharma Inc	Vincent A Vultaggio	PAO and PFO	Sale of securities on an exchange or to another person at price $ 2.42 per share.	06 Feb 2026	6,894	146,506	-	2.4	16,699	Common Stock
Zentalis Pharma Inc	Vincent A Vultaggio	PAO and PFO	Sale of securities on an exchange or to another person at price $ 2.39 per share.	06 Feb 2026	3,379	153,400	-	2.4	8,086	Common Stock
Zentalis Pharma Inc	Vincent A Vultaggio	PAO and PFO	Sale of securities on an exchange or to another person at price $ 2.55 per share.	02 Feb 2026	2,540	187,286	-	2.6	6,477	Common Stock
Zentalis Pharma Inc	Vincent A Vultaggio	PAO and PFO	Sale of securities on an exchange or to another person at price $ 2.51 per share.	02 Feb 2026	556	186,730	-	2.5	1,398	Common Stock
Zentalis Pharma Inc	Vincent A Vultaggio	PAO and PFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jan 2026	100,000	100,000	-		-	Stock Option (Right to Buy)
Zentalis Pharma Inc	Vincent Vultaggio A	PAO and Interim PFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2025	158,586	192,441	-		0	Common Stock
Zentalis Pharma Inc	Vincent Vultaggio A	PAO and Interim PFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2025	35,633	35,633	-		-	Stock Option (Right to Buy)
Zentalis Pharma Inc	Vincent Vultaggio A	PAO and Interim PFO	Sale of securities on an exchange or to another person at price $ 1.71 per share.	03 Feb 2025	2,615	189,826	-	1.7	4,476	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades